Your browser doesn't support javascript.
loading
Efficacy of Sofosbuvir and Ledipasvir in Comparison to Sofosbuvir and Daclatasvir in Management of Egyptian Chronic Hepatitis C Patients
Nouh, Israa Alaa; Mostafa, Adila; Elsheimy, Eman; Sameh, Sief; Basem, Eysa,.
Affiliation
  • Nouh, Israa Alaa; Tropical Medicine Department , National Hepatology and Tropical Medicine R R Research Institute. AL-Azhar. EG
  • Mostafa, Adila; Hepatology , Gastroenterology and Infectious Diseases Department ,Faculty f o of Medicine for Girls. AL-Azhar. EG
  • Elsheimy, Eman; 2 Hepatology , Gastroenterology and Infectious Diseases Department ,Faculty f o of Medicine for Girls, AL-Azhar. AL-Azhar. EG
  • Sameh, Sief; Tropical Medicine Department , National Hepatology and Tropical Medicine R R Research Institute. AL-Azhar. EG
  • Basem, Eysa,; Tropical Medicine Department , National Hepatology and Tropical Medicine R R Research Institute. AL-Azhar. EG
Afro-Egypt. j. infect. enem. dis ; 10(2): 163-173, 2022. tables, figures
Article de En | AIM | ID: biblio-1426649
Bibliothèque responsable: CG1.1
ABSTRACT
In Egypt, the prevalence of hepatitis C virus (HCV) antibodies is the highest worldwide by 7.6%. Applying efficient treatment protocol on large scale could decrease HCV prevalence as well as disease burden.The aim of this study is to compare the efficacy of Sofosbuvir plus ledipasvir versus Sofosbuvir plus daclatasvir in management of chronic hepatitis C Egyptian patients with either easy to treat (naive patients with Child score A5)or difficult to treat (interferon experienced).
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
Recherche sur Google
Texte intégral: 1 Indice: AIM Sujet Principal: Résultat thérapeutique / Hépatite C chronique Type d'étude: Guideline / Observational_studies / Risk_factors_studies Limites du sujet: Humans langue: En Texte intégral: Afro-Egypt. j. infect. enem. dis Année: 2022 Type: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
Recherche sur Google
Texte intégral: 1 Indice: AIM Sujet Principal: Résultat thérapeutique / Hépatite C chronique Type d'étude: Guideline / Observational_studies / Risk_factors_studies Limites du sujet: Humans langue: En Texte intégral: Afro-Egypt. j. infect. enem. dis Année: 2022 Type: Article